Spectrum Health participating in clinical trials for alternative to open-heart surgery

The Spectrum Health System is participating in a clinical trial to evaluate a transcatheter alternative to open-heart surgery for patients with severe aortic stenosis. The Medtronic CoreValve U.S. Clinical Trial is under way at the Fred and Lena Meijer Heart Center in Grand Rapids. The center is among about 40 hospitals across the country that will participate in this five-year trial.
Aug 2, 2011


The CoreValve System is designed to provide a minimally invasive, transcatheter treatment option for patients with symptomatic, severe aortic stenosis who are at high risk or are ineligible for open-heart surgery. Worldwide, approximately 300,000 people have been diagnosed with this condition (100,000 in the U.S.).

Approximately one-third of these patients are deemed at too high of a risk for open-heart surgery, the only therapy with significant clinical effect that is currently available in the U.S.

To read more of this story, see Tuesday's print or e-edition of the Grand Haven Tribune.

For more information about the Medtronic CoreValve U.S. Clinical Trial, visit www.aorticstenosistrial.com.

The Heart & Vascular Institute is currently enrolling patients in the trial. For more information about participating in this clinical trial, contact Dr. Merhi at 616-456-9553 or Dr. Heiser 616-459-7258, or e-mail CoreValve@spectrumhealth.org.


Post a Comment

Log in to your account to post comments here and on other stories, galleries and polls. Share your thoughts and reply to comments posted by others. Don't have an account on GrandHavenTribune.com? Create a new account today to get started.